Publiziert in: Marktpuls, Unternehmen
Frei

Roche Investor Update: Invitation to Roche's Half Year Results 2015 Donnerstag, 25. Juni 2015 - 10:11

Roche - Investor Update

Basel, 25 June 2015
Invitation to Roche's Half Year Results 2015
Roche will publish its Half Year Results for 2015 prior to the opening of the Swiss Stock Exchange on 23rd July, 2015.
7:00 CEST / 6:00 BST / 1:00 AM EDT / 10:00 PM PDT (evening before)
Release will be e-mailed and posted on the Roche IR website click here.
Presentation slides will be posted on the Roche IR website click here.
We would like to invite you to watch the live video webcast or to dial in as outlined below:
Up 

Thursday, 23th July, 2015

 
13:00 - 14:30 CEST / 12:00 - 13:30 BST /
07:00 - 08:30 AM EDT / 04:00 - 05:30 AM PDT
Live video webcast and conference call will start with presentations by senior management followed by a Q&A session (questions can be asked via phone and webcast).

Presenters:

Severin Schwan, CEO Roche Group
Alan Hippe, Chief Financial and IT Officer
Daniel O'Day, COO Pharmaceuticals
Roland Diggelmann, COO Diagnostics
Download this event to your calendar. > click here
To access the live video webcast, please > click here and access the webcast under "Current Events".
To listen to the conference call, please dial in to the conference 10-15 min prior to the scheduled start, using the following numbers:
+41 (0) 58 310 5000 (Europe and ROW))
+44 (0) 203 059 5862 (UK)
+1 (1) 631 570 5613 (USA Toll Free)
To expedite the registration process on the day of the conference call, you may pre-register for the event. > click here
Up 

Replay

 
A replay of the conference call will be available following the event, for 48 hours. Access is by dialing:
+41 (0) 91 612 4330 (Europe and ROW)
+44 (0) 207 108 6233 (UK)
+1 (1) 631 982 4566 (USA)
and will be asked to enter the ID 15224 followed by the #sign.
A replay of the webcast will be available on demand on the Roche website. > click here
Best regards,
Karl Mahler
Head of Investor Relations
Up
Roche Investor Relations
Dr. Karl Mahler 
Phone: +41 61 68-78503 
e-mail: karl.mahler@roche.com
Dr. Sabine Borngräber 
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli 
Phone: +41 61 68-75284 
e-mail: bruno.eschli@roche.com
Dr. Tamer Farhan 
Phone: +41 61 68-82552 
e-mail: tamer.farhan@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814 
e-mail: birgit.masjost@roche.com
 
Investor Relations North America
Dr. Stefan Foser 
Phone: +1 650 467-2016 
e-mail: foser.stefan@gene.com
Nina Goworek 
Phone: +1 650 467-8737 
e-mail: goworek.nina@gene.com
Ekaterine Kortkhonjia Ph.D. 
Phone: +1 650 467-5873 
e-mail: kortkhonjia.ekaterine@gene.com
 
25 June, 2015 Content owner:   Roche Investor Relations    ©2015 F. Hoffmann-La Roche Ltd.